1200 - Johnson - Critical Care

34
Recent Advances in Critical Care Medicine: A Case Based Review Margaret M. Johnson, MD Associate Profe ssor of Medicine Chair, Division of Pulmonary Medicine Mayo Clinic Florida [email protected]

Transcript of 1200 - Johnson - Critical Care

7/27/2019 1200 - Johnson - Critical Care

http://slidepdf.com/reader/full/1200-johnson-critical-care 1/34

Recent Advances in Critical Care

Medicine: A Case Based ReviewMargaret M. Johnson, MD

Associate Professor of Medicine

Chair, Division of Pulmonary MedicineMayo Clinic Florida

[email protected]

7/27/2019 1200 - Johnson - Critical Care

http://slidepdf.com/reader/full/1200-johnson-critical-care 2/34

33 year old non-smoking, previously

healthy female

• No prior hospitalizations

• T 38.9 (po)

• RR 22 bpm

• HR 138 bpm• BP 70/40

• Coarse rhonchi bilaterally

• O2 saturation 82%

 – Up to 95% on face mask

• Mottled skin

• Anuric

• Lactate 6.2

7/27/2019 1200 - Johnson - Critical Care

http://slidepdf.com/reader/full/1200-johnson-critical-care 3/34

Overview

• Updated Surviving Sepsis Guidelines – Management of shock

• Fluid resuscitation

• Vasopressor support

• Role of steroids

• Respiratory management

 – Intubation

 – Ventilator management• High frequency ventilation, prone ventilation

• Management strategies to decrease delirium

• Outcome

7/27/2019 1200 - Johnson - Critical Care

http://slidepdf.com/reader/full/1200-johnson-critical-care 4/34

SURVIVING SEPSIS GUIDELINES: 2012

Joint collaboration between SSCM and European Respiratory

Society

Third edition

No industry funding used in revision process

Critical Care Medicine February 2013www.survivingsepsis.org 

7/27/2019 1200 - Johnson - Critical Care

http://slidepdf.com/reader/full/1200-johnson-critical-care 5/34

Sepsis: Fluid Resuscitation

• Crystalloid, normally saline, is primary choice

 – Initial: 30 ml/kg = 2.1 L for 70 kg

 – Subsequent boluses to defined endpoint

 – Endpoints:• Normal mixed venous oxygen saturation 65-70%

• Normal lactate

• Urine output > 0.5 ml/kg/hr

• MAP > 65 mm Hg• Weak indication for albumin (Grade 2B)

• Avoid hetastarch with high molecular weight (> 200 kD)

7/27/2019 1200 - Johnson - Critical Care

http://slidepdf.com/reader/full/1200-johnson-critical-care 6/34

Potential Dangers of Saline

• Saline administration

 – Hypertonic relative to blood

 – Often causes hyperchloremic metabolic acidosis

• Does it cause renal injury ?• Prospective, sequential, single institution pilot study

• Chloride restrictive v. chloride liberal

 – Restrictive

• Lactated solution or plasma-lyte• N = 776 (liberal)

• N = 773 (restrictive)

Nor’azim MY. JAMA 2012; 308(15):1566-1572

7/27/2019 1200 - Johnson - Critical Care

http://slidepdf.com/reader/full/1200-johnson-critical-care 7/34

Results

• Limiting use of normal saline

 – Less acute kidney injury and reduced need for dialysis in

hospital

 – No difference in length of stay or mortality – No difference in need for dialysis after hospital discharge

• Current take home

 – Uncertain

 – Have a reason for giving saline – Probably should consider alternative fluid if large volume

required

Nor’azim MY. JAMA 2012; 308(15):1566-1572

7/27/2019 1200 - Johnson - Critical Care

http://slidepdf.com/reader/full/1200-johnson-critical-care 8/34

Sepsis:Vasopressors

• Norepinephrine is first choice – Grade 1B

• Epinephrine is an alternative

• Vasopressin can be added to norepinephrine• Dopamine use limited by tachycardia

 – NO INDICATION FOR RENAL DOSE

DOPAMINE

• Dobutamine if cardiac dysfunction or

persistent shock despite volume

• Value of Bedside ECHO

7/27/2019 1200 - Johnson - Critical Care

http://slidepdf.com/reader/full/1200-johnson-critical-care 9/34

Are Steroids Indicated ???

Sigh….Will we ever know 

• Current recommendations

 – Don’t perform cosotropyn stimulation test to decide need forsteroids

 – Consider steroids with persistent shock despite fluids andvasopressors

 – Hydrocortisone 200 mg/day

• Boluses or infusion

• Avoid dexamethasone

 – Don’t need fludrocortisone if hydrocortisone used 

 – Wean steroids when off vasopressors

7/27/2019 1200 - Johnson - Critical Care

http://slidepdf.com/reader/full/1200-johnson-critical-care 10/34

Six Hours Later

BP 106/72

HR 90

RR 32

Received 4 L NSSNorepinephrine 12

ug/min

ABG:

7.32/42/310 on 100% O2

PaO2/fiO2 310

7/27/2019 1200 - Johnson - Critical Care

http://slidepdf.com/reader/full/1200-johnson-critical-care 11/34

Intubation: Safety of Etomidate

• Meta-analysis: Etomidate associated with

 – Increased risk of death

• 865 evaluated for mortality, RR 1.2 (1.02-1.42)

 – Increased risk of adrenal insufficiency• 1303 evaluated with cosotropyn stimulation test, RR

1.33 (1.22-1.46)

• Take home

 – Causality not concluded, but….alternative should beconsidered, especially in sepsis

Chan CM Crit Care Med 2012 40(11) 2945

7/27/2019 1200 - Johnson - Critical Care

http://slidepdf.com/reader/full/1200-johnson-critical-care 12/34

Does She Have ARDS ?

New Berlin Definition

• Maintains emphasis on PaO2/fiO2 ratio – < 300 but > 200 = mild – < 200 but > 100 = moderate – < 100 = severe

• Other components – Acute ( < 7 days)

• Difficulty with chronic disease

 – Bilateral infiltrates• Either computed tomography or chest x-ray

 – No need to exclude heart failure• Heart failure can’t “solely explain respiratory

failure”  JAMA 2012; 307 (23):2526

7/27/2019 1200 - Johnson - Critical Care

http://slidepdf.com/reader/full/1200-johnson-critical-care 13/34

Value of “New Berlin” Definition 

• Improved prognostic value:

 – PaO2/fiO2 < 300 but > 200 = mild• 27% mortality

 – PaO2/fiO2 < 200 but > 100 = moderate• 32% mortality

 – PaO2/fiO2 < 100 = severe

• 45% mortality

7/27/2019 1200 - Johnson - Critical Care

http://slidepdf.com/reader/full/1200-johnson-critical-care 14/34

Lower tidal volumes associated

with decreased mortality

6 cc/kg IBW v. 12 cc/kg

 ARDSNet NEJM 2000

7/27/2019 1200 - Johnson - Critical Care

http://slidepdf.com/reader/full/1200-johnson-critical-care 15/34

Low Tidal Volume Ventilation in

Absence of ARDS

• Meta-analysis of patients WITHOUT ARDS

• Tidal volume

 – 6.5 v. 10.6 cc/kg IBW

• Lower tidal volumes associated with:

 – Lower chance of developing ARDS

 – Decreased pulmonary infection or atelectasis

 – Mortality

Neto AS. JAMA 2012; 307 (23):2526

7/27/2019 1200 - Johnson - Critical Care

http://slidepdf.com/reader/full/1200-johnson-critical-care 16/34

Is High Frequency Ventilation Helpful?

• OSCAR Trial – 795 patients

 – Multi-centered in UK

 – Identical 30 day mortality (41%)» Young D NEJM 2013;368:806

• OSCILLATE Trial

 – High frequency oscillator trial stopped

prematurely due to increased mortality

• 47% v. 35%

» Ferguson N. NEJM 2013

7/27/2019 1200 - Johnson - Critical Care

http://slidepdf.com/reader/full/1200-johnson-critical-care 17/34

Is Prone Positioning Beneficial ?

• Background

 – Prone positioning has previously been shown to

improve oxygenation but not mortality in ARDS

• 237 patients proned v. 229 control

 – Severe ARDS PaO2: fiO2 < 150

• Started early

 – Within 36 hrs of ARDS

 – 16 hrs/session

• 28 day mortality

 – 16% (prone) v. 32.8% (control) (p< 0.001)

Guerin C. NEJM 2013;368:2159

7/27/2019 1200 - Johnson - Critical Care

http://slidepdf.com/reader/full/1200-johnson-critical-care 18/34

Is Prone Positioning Beneficial ?

• Not blinded• Control group-higher

acuity scores

• Practical implementation – Did not use specialty beds

 – Proning was not

associated with increasedcomplications

• BUT…these were

experienced centers

Guerin C. NEJM 2013;368:2159

7/27/2019 1200 - Johnson - Critical Care

http://slidepdf.com/reader/full/1200-johnson-critical-care 19/34

9 Days Later

• “Agitated and combative” 

• Receiving continuous infusions of

lorazepam and fentanyl• Agitation limits weaning attempts

• Is she delirious?

 – Assessment of delirium

 – Prevention and treatment

7/27/2019 1200 - Johnson - Critical Care

http://slidepdf.com/reader/full/1200-johnson-critical-care 20/34

ICU Delirium

• Exact incidence is unknown but common – Up to 85% in some series

• Negatively impacts both short and long term

outcomes• Short term

• Length of stay & duration of ventilation

• Mortality

• Long term

• Cognition

• Depression and post traumatic stress disorder

7/27/2019 1200 - Johnson - Critical Care

http://slidepdf.com/reader/full/1200-johnson-critical-care 21/34

Structural Changes Correlate with

Delirium and Cognition

Hopkins, RO Crit Care Med 2012

7/27/2019 1200 - Johnson - Critical Care

http://slidepdf.com/reader/full/1200-johnson-critical-care 22/34

Greater Ventricle/Brain Ratio

Correlates with Delirium

Hopkins, RO Crit Care Med 2012

7/27/2019 1200 - Johnson - Critical Care

http://slidepdf.com/reader/full/1200-johnson-critical-care 23/34

Recognition of Delirium

• Objective tools

 – Confusion Assessment Method CAM-ICU

• Performed in conjunction with assessment of level of

sedation (Richmond agitation and sedation score-RASS)• www.icudelirium.org

• May be “hyperactive” or “hypoactive” 

7/27/2019 1200 - Johnson - Critical Care

http://slidepdf.com/reader/full/1200-johnson-critical-care 24/34

Ely EW. 2002

7/27/2019 1200 - Johnson - Critical Care

http://slidepdf.com/reader/full/1200-johnson-critical-care 25/34

THINK…Rather than prescribe… 

• Toxic environments

 – Shock, CHF

 – “Delirogenic Drugs” 

• Hypoxemia

 – Consider Haloperidol

• Infection/Immobilization

• Nonpharmacologic interventions/Nutrition

 – Eyeglasses, Hearing aides, re-orientation, sleep wake

cycle restoration, sleep hygiene, noise control

• K+ electrolyte abnormalities

7/27/2019 1200 - Johnson - Critical Care

http://slidepdf.com/reader/full/1200-johnson-critical-care 26/34

Risk of Delirium Associated with Use of Lorazepam &

Severity of Illness

Pandhandipari P. Anestheshiology 2006

LORAZEPAM DOSE (MG) APACHE SCORE

   I   N   C   I   D   E   N   C   E

   O   F   D   E   L   I   R   I   U   M 

7/27/2019 1200 - Johnson - Critical Care

http://slidepdf.com/reader/full/1200-johnson-critical-care 27/34

Less delirium with Dexmedetomidate

v. Midazolam

Rikker RR. JAMA 2009

N = 375

Similar time at

goal sedation

7/27/2019 1200 - Johnson - Critical Care

http://slidepdf.com/reader/full/1200-johnson-critical-care 28/34

Sedation Comparison

• MENDS Trial (n = 106)

 – Dexmetomonidine v. lorazepam in mechanically

ventilated

 – More days alive without delirium or coma with

dexmetomidine» Pandharipande JAMA 2007

• Reade, et al ( n=20)

 – Dexmetomidine v. haldoperidol intubated patientswhose delirium prevented extubation

 – Extubation sooner in dexmetomidine group» Crit Care 2009

7/27/2019 1200 - Johnson - Critical Care

http://slidepdf.com/reader/full/1200-johnson-critical-care 29/34

Sleep, Delirium, and Cognition

• Observational pre and post intervention study

• Daily checklist to improve sleep and maintain

day-night cycles

• 634 (pre) v. 826 (post) patient days

• Subjective ratings of sleep not improved but

less delirium and less noise post intervention

Kamdar BB. Crit Care Med 2013

7/27/2019 1200 - Johnson - Critical Care

http://slidepdf.com/reader/full/1200-johnson-critical-care 30/34

Now What

• Discharged from the ICU on Day 17

• Home on Day 23

• What should she and her family expect?

7/27/2019 1200 - Johnson - Critical Care

http://slidepdf.com/reader/full/1200-johnson-critical-care 31/34

Denehy Curr Opin Crit Care Med 2013

7/27/2019 1200 - Johnson - Critical Care

http://slidepdf.com/reader/full/1200-johnson-critical-care 32/34

Ways to Improve Functional Recovery

• In ICU – Limit sedation use and development of delirium

 – Utilize early mobility programs, physical, and

occupational therapy

 – Try to enhance sleep

• After ICU

 – Coordinated post-discharge care including

physical, occupational, and cognitive rehabilitation

 – Inform patients and caregivers that functional

limitations' commonly persist

7/27/2019 1200 - Johnson - Critical Care

http://slidepdf.com/reader/full/1200-johnson-critical-care 33/34

Take Home Points

• New sepsis guidelines – Fluid 30 cc/kg normal saline

 – No renal dose dopamine

 –  Avoid high molecular weight hetastarch –  Norepinephrine (+/- vasopressin)

 – No role for cosotropyn stimulation test

 – Use hydrocortisone as steroid for stress dose – Chloride rich solutions associated with

development of kidney injury

7/27/2019 1200 - Johnson - Critical Care

http://slidepdf.com/reader/full/1200-johnson-critical-care 34/34

Take Home Points

• Caution with the use of etomidate -especially in sepsis• Low tidal volume ventilation beneficial even in absence of ARDS

• High frequency ventilation has not shown mortality benefit

• Prone positioning associated with improved mortality

• Delirium is common and associated with worsened outcomes – Objectively assess

 – ? Avoid/Limit benzodiazepines

 – Consider nonpharmacological therapies

• Long term impairments often follow critical illness

 – Inform patients and caregivers

 – Strategies to improve long term outcomes are ongoing